Stents Market Analysis

Stents Market Analysis

To get key market trends

  Download Free Sample

Based on product, the market is segmented into vascular stents and non-vascular stents. The vascular stent segment is anticipated to reach USD 13 billion by 2032.
 

• Vascular stents are used in opening narrowed blood vessels and clearing blockages. The growing burden of cardiovascular diseases will fuel the product demand. Furthermore, the surge in demand for surgeries among the population is expected to boost the segment expansion.
   
• Vascular stents are used to prevent the stenosis of blood vessels and restore blood flow. Increasing rates of cardiovascular disease due to sedentary lifestyle and smoking will boost the demand for vascular stents.
• Moreover, high growth rate is attributable to growing burden of coronary artery disease and technological advancements for development of advanced vascular stents.
   

The stents market by material is categorized into metal and polymer. The metal segment dominates the market with the revenue of around USD 7.5 billion in 2023.
 

• Metal is the material of choice for stents due to advantages such as lower rates of stent fracture, flexibility and biocompatibility. Integration of metallic stents with biodegradable polymers to overcome the limitations of conventional will be another factor instrumental in propelling the segment growth.
   
• Furthermore, the durable nature of metal stents and the low rate of stent fracture will drive the market growth.
   

Based on type, the stents market is segmented into self-expandable and balloon expandable. The balloon expandable stent segment held leading revenue share in 2023 and is anticipated to reach USD 8.8 billion by 2032.
 

• Balloon expandable stents support high radial outward force due to their rigidity. Furthermore, they offer long-term integrity and higher elasticity, thereby positively impacting the segmental expansion over the forecast period.
   
• Moreover, high growth rate is due to better radial stiffness, high adoption rate and approvals for balloon expandable stents from regulatory bodies.  
   

The stents market by end-use is categorized into hospitals, ambulatory surgical centers, and other end-users. The hospitals segment held majority revenue share and was valued at around USD 6.9 billion in 2023.
 

• The demand for stents in hospitals continues to surge, driven by the rising prevalence of cardiovascular diseases and advancements in interventional cardiology procedures. As hospitals strive to meet the growing needs of patients requiring stent implantation, there's a heightened emphasis on stocking a diverse range of stent types, including drug-eluting, bare metal stents, and bioresorbable stents, to cater to individual patient requirements.
   
• Additionally, the shift towards minimally invasive techniques has bolstered the demand for stents, as they offer effective solutions with reduced recovery times and improved patient outcomes.
   
• Availability of skilled surgeons and better post-operative care in hospitals will drive the segment expansion. Furthermore, supply agreements between hospitals and manufacturers will drive the industry expansion.
   

North America stents market accounted for USD 2.1 billion revenue in 2023 and is predicted to witness substantial market growth.
 

• The demand for stents in North America is on the rise due as, the region has a high prevalence of cardiovascular diseases, such as coronary artery disease and peripheral artery disease, which necessitate the use of stents for treatment. Additionally, there is a growing aging population in the region, leading to an increased incidence of cardiovascular conditions and subsequent demand for stents.
   
• Moreover, technological advancements in stent design and materials have contributed to the increasing demand, as newer stents offer improved efficacy and safety profiles.
   
• Furthermore, favorable reimbursement policies for stenting procedures in the region have encouraged healthcare providers to offer these interventions more frequently, further boosting the demand for stents.